Tag: Intellia Therapeutics stock analysis
Intellia Therapeutics Price Target Lowered to $40 by JonesResearch – TipRanks
Intellia Therapeutics, a biotechnology company, recently had its price target lowered to $40 by JonesResearch, according to TipRanks. It is important to note that...